Diagnostic Report: Patient Name: Dutta Deva Kumar DUTTM24114531 0031TK032614
Diagnostic Report: Patient Name: Dutta Deva Kumar DUTTM24114531 0031TK032614
Diagnostic Report: Patient Name: Dutta Deva Kumar DUTTM24114531 0031TK032614
CLINICAL INFORMATION :
SRF ID : 1930300337135
MOLECULAR BIOLOGY
SARS COV -2 REAL TIME PCR
Comments
References: Laboratory testing for Corona Virus Disease 2019(COVID-19) in suspected human cases,WHO interim guidelines 2nd March 2020.
Ct value: >33 but < 35 are borderline cases, same should be tested on a fresh sample after 3-4 days if clinically indicated.
Disclaimer : There are no reliable studies to definitively prove a direct correlation between disease severity/ infectiousness and Ct values,therefore it
is not recommended to rely on numerical
Ct values for determining infectiousness of COVID-19 patients and deciding patient management protocols.
Note:
1.ICMR Registration number for COVID 19 is SRLLWBK
2..Negative result does not rule out the possibility of Covid 19 infection.Presence of inhibitors,mutations and insufficient RNA specific to SARS-CoV-2
can influence the test result .Kindly correlate the
result with clinical findings.
3..Covid -19 Test conducted as per kits approved by ICMR/USFDA.
4.Kindly consult referring Physician / Authorized Govt.hospital for appropriate follow up.
Interpretation(s)
SARS COV -2 REAL TIME PCR-
SARS-CoV-2, formerly known as 2019-nCoV, is the causative agent of the coronavirus disease 2019 (COVID-19). Main symptoms of the disease include fever, cough and
shortness of breath. The virus is spread via person-to-person contact through respiratory droplets produced when a person coughs or sneezes. The SARS-CoV-2 RNA is
generally detectable in nasopharyngeal/oropharyngeal swabs during the acute phase of infection. Positive results are indicative of active infection. Real Time PCR assay
targets specific genes and can be used for diagnosis of SARS-CoV-2 virus infection which contributes to severe upper respiratory distress and complications.
Positive result indicates that RNA from SARS-CoV-2 was detected in the specimen, and the patient is considered infected with the virus and presumed to be contagious.
Negative test result for this test means that SARS-CoV-2 RNA was not detected in the specimen above the limit of detection of the assay.
Limitations:
• Negative results do not preclude COVID-19 and should not be used as the sole basis for patient management decisions. Negative results must be combined with clinical
observations, patient history, and epidemiological information.
• Positive results do not rule out bacterial infection or co-infection with other viruses.
• Optimum specimen types and timing for peak viral levels during infections caused by 2019-nCoV have not been determined. Collection of multiple specimens (types and
time points) from the same patient may be necessary to detect the virus.
• Follow-up testing may particularly be important if patient has a clinical picture of viral pneumonia, a potential exposure history, and/or radiographic findings (chest CT or
MRI scan) consistent with COVID -19 pneumonia. However repeat testing in the near-term after clearance (within 90 days) should be avoided as prolonged shedding of
Page 1 Of 2
DIAGNOSTIC REPORT
CLINICAL INFORMATION :
SRF ID : 1930300337135
References:
1. Laboratory testing for coronavirus disease 2019 (COVID-19) in suspected human cases. Interim guidance. World Health Organization.
2. Druce et al. JCM. 2011
3. N. Engl. J. Med. 2020, 382, 929–936
**End Of Report**
Please visit www.srlworld.com for related Test Information for this accession
Page 2 Of 2